Publications
2017 Master Transcriptional Regulators in Cancer: Discovery via Reverse Engineering Approaches and Subsequent Validation
 
Cancer Research 2017, 77(9) pp2186-2190, doi:10.1158/0008-5472.CAN-16-1813
[Link to Article]
Bruce Moran, Arman Rahman, Katja Palonen, Fiona T. Lanigan and William M. Gallagher
2017 The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting
 
Breast Cancer Research 2017, 19(1):99, doi:10.1186/s13058-017-0861-2
[Link to Article]
Severson TM, Wolf DM, Yau C, Peeters J, Wehkam D, Schouten PC, Chin SF, Majewski IJ, Michaut M, Bosma A, Pereira B, Bismeijer T, Wessels L, Caldas C, Bernards R, Simon IM, Glas AM, Linn S, van 't Veer L.
2017 High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy–Treated Patients—Results from a Population-Based Breast Cancer Cohort
 
Clinical Cancer Research 2017, 23(3) pp766-777, doi:10.1158/1078-0432.CCR-16-1095
[Link to Article]
Karin Elebro, Signe Borgquist, Ann H. Rosendahl, Andrea Markkula, Maria Simonsson, Karin Jirström, Carsten Rose, Christian Ingvar and Helena Jernström
2017 Combined and individual tumor-specific expression of insulin-like growth factor-I receptor, insulin receptor and phospho-insulin-like growth factor-I receptor/insulin receptor in primary breast cancer: Implications for prognosis in different treatment groups
 
Oncotarget 2017, 8(6) pp 9093-9107, doi:10.18632/oncotarget.14082
[Link to Article]
Björner S*, Rosendahl AH*, Simonsson M, Markkula A, Jirström K, Borgquist S, Rose C, Ingvar C, Jernström H.
2017 The prognostic impact of COX-2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor size
 
International Journal of Cancer 2017, 140(1) 163-175, doi:10.1002/ijc.30432
[Link t\o Article]
Simonsson M, Björner S, Markkula A, Nodin B, Jirström K, Rose C, Borgquist S, Ingvar C, Jernström H.
2017 Therapeutic Rationale to Target Highly Expressed CDK7 Conferring Poor Outcomes in Triple-Negative Breast Cancer
 
Cancer Research 2017, 77:14 doi:10.1158/0008-5472.CAN-16-2546
[Link to Article]
Bo Li, Triona Ni Chonghaile, Yue Fan, Stephen F. Madden, Rut Klinger, Aisling E. O'Connor, Louise Walsh, Gillian O'Hurley, Girish Mallya Udupi, Jesuchristopher Joseph, Finbarr Tarrant, Emer Conroy, Alexander Gaber, Suet-Feung Chin, Helen A. Bardwell, Elena Provenzano, John Crown, Thierry Dubois, Sabine Linn, Karin Jirstrom, Carlos Caldas, Darran P. O'Connor and William M. Gallagher
2016 Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer
 
Scientific Reports 2016, 6:18517, doi:10.1038/srep18517
[Link to Article]
Magali Michaut, Suet-Feung Chin, Ian Majewski, Tesa M. Severson, Tycho Bismeijer, Leanne de Koning, Justine K. Peeters, Philip C. Schouten, Oscar M. Rueda, Astrid J. Bosma, Finbarr Tarrant, Yue Fan, Beilei He, Zheng Xue, Lorenza Mittempergher, Roelof J.C. Kluin, Jeroen Heijmans, Mireille Snel, Bernard Pereira, Andreas Schlicker, Elena Provenzano, Hamid Raza Ali, Alexander Gaber, Gillian O’Hurley, Sophie Lehn, Jettie J.F. Muris, Jelle Wesseling, Elaine Kay, Stephen John Sammut, Helen A. Bardwell, Aurélie S. Barbet, Floriane Bard, Caroline Lecerf, Darran P. O’Connor, Daniël J. Vis, Cyril H. Benes, Ultan McDermott, Mathew J. Garnett, Iris M. Simon, Karin Jirström, Thierry Dubois, Sabine C. Linn, William M. Gallagher, Lodewyk F.A. Wessels, Carlos Caldas & Rene Bernards
2015 Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients
 
BMC Clinical Pathology, 2015, 15:8, doi:10.1186/s12907-015-0008-2
[Link to Article]
Emma Gustbée, Helga Tryggvadottir, Andrea Markkula, Maria Simonsson, Björn Nodin, Karin Jirström, Carsten Rose, Christian Ingvar, Signe Borgquist and Helena Jernström
2015 Robust BRCA1-like classification of copy number profiles of samples repeated across different datasets and platforms
 
Molecular Oncology, 2015, 9(7):1274-1286, doi:10.1016/j.molonc.2015.03.002
[Link to Article]
Philip C. Schouten, Anita Grigoriadis, Thomas Kuilman, Hasan Mirza, Johnathan A. Watkins, Saskia A. Cooke, Ewald van Dyk, Tesa M. Severson, Oscar M. Rueda, Marlous Hoogstraat, Caroline V.M. Verhagen, Rachael Natrajan, Suet-Feung Chin, Esther H. Lips, Janneke Kruizinga, Arno Velds, Marja Nieuwland, Ron M. Kerkhoven, Oscar Krijgsman, Conchita Vens, Daniel Peeper, Petra M. Nederlof, Carlos Caldas, Andrew N. Tutt, Lodewyk F. Wessels, Sabine C. Linn
2015 Combined androgen and estrogen receptor status in breast cancer: treatment prediction and prognosis in a population-based prospective cohort
 
Clinical Cancer Research, 2015, doi:10.1158/1078-0432.CCR-14-2564
[Link to Article]
Karin Elebro, Signe Borgquist, Maria Simonsson, Andrea Markkula, Karin Jirström, Christian Ingvar, Carsten Rose, Helena Jernström
2015 Delineating transcriptional networks of prognostic gene signatures refines treatment recommendations for lymph node-negative breast cancer patients
 
FEBS Journal, 2015, doi:10.1111/febs.13354
[Link to Article]
Fiona Lanigan, Gerard L. Brien, Yue Fan, Stephen F. Madden, Emilia Jerman, Fatima Aloraifi, Karsten Hokamp, Eiseart J. Dunne, Amanda J. Lohan, Louise Flanagan, James C. Garbe, Martha R. Stampfer, Marie Fridberg, Karin Jirström, Cecily M. Quinn, Brendan Loftus, William M. Gallagher, James Geraghty, Adrian P. Bracken
2015 BRCA1-like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potential
 
Molecular Oncology, 2015, doi:10.1016/j.molonc.2015.04.011
[Link to Article]
Tesa M. Severson, Justine Peeters, Ian Majewski, Magali Michaut, Astrid Bosma, Philip C. Schouten, Suet-Feung Chin, Bernard Pereira, Mae A. Goldgraben, Tycho Bismeijer, Roelof J.C. Kluin, Jettie J.F. Muris, Karin Jirström, Ron M. Kerkhoven, Lodewyk Wessels, Carlos Caldas, René Bernards, Iris M. Simon, Sabine Linn
2015 Epidemiologic Design and Analysis for Proteomic Studies: A Primer on -Omic Technologies
 
American Journal of Epidemiology, 2015, 181(9):635-647, doi:10.1093/aje/kwu462
[Link to Article]
Harald Mischak, Elena Critselis, Samir Hanash, William M. Gallagher, Antonia Vlahou, John P.A. Ioannidis
2015 PIK3CA mutations are associated with decreased benefit to neoadjuvant human epidermal growth factor receptor 2- targeted therapies in breast cancer
 
Journal of Clinical Oncology, 2015, 33(12):1334-1339, doi:10.1200/JCO.2014.55.2158
[Link to Article]
Ian J. Majewski, Paolo Nuciforo, Lorenza Mittempergher, Astrid J. Bosma, Holger Eidtmann, Eileen Holmes, Christos Sotiriou, Debora Fumagalli, Jose Jimenez, Claudia Aura, Ludmila Prudkin, Maria Carmen Díaz-Delgado, Lorena de la Peña, Sherene Loi, Catherine Ellis, Nikolaus Schultz, Evandro de Azambuja, Nadia Harbeck, Martine Piccart-Gebhart, René Bernards and José Baselga
2014 Impact of COX2 genotype, ER status and body constitution on risk of early events in different treatment groups of breast cancer patients
 
International Journal of Cancer, 2014, 135:1989-1910, doi:10.1002/ijc.28831
[Link to Article]
Andrea Markkula, Maria Simonsson, Ann H. Rosendahl, Alexander Gaber, Christian Ingvar, Carsten Rose and Helena Jernström
2014 Development of a BRCA1-like signature in Triple Negative breast cancers within the RATHER (Rational Therapy for Breast Cancer) consortium
 
Annals of Oncology, 2014, 25(suppl 1):i8. doi:10.1093/annonc/mdu066.3
[Link to Article]
I.M. Simon, J. Peeters, T. Severson, I. Majewski, A. Bosma, C. Caldas, S. Chin, R. Bernards, S. Linn
2014 Garbage in, Garbage out: A Critical Evaluation of Strategies Used for Validation of Immunohistochemical Biomarkers
 
Molecular Oncology , 2014, 8(4):783-798, doi:10.1016/j.molonc.2014.03.008
[Link to Article]
Gillian O’Hurley, Evelina Sjöstedt, Arman Rahman, Bo Li, Caroline Kampf, Fredrik Pontén, William M. Gallagher, Cecilia Lindskog
2013 Investigation of Molecular Alterations of AKT-3 in Triple Negative Breast Cancer
 
Histopathology, 2013 Oct 19 doi:10.1111/his.12313
[Link to Article]
Gillian O'Hurley, Etáin Daly, Anthony O'Grady, Robert Cummins, Cecily Quinn, Louise Flanagan, Aisling Pierce, Yue Fan, Miriam A. Lynn, Máirín Rafferty, Dara Fitzgerald, Fredrik Pontén, Michael J. Duffy, Karin Jirström, Elaine W. Kay, William M. Gallagher
2013 Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis
 
Carcinogenesis, 2013, 34(10):2300-2308, doi:10.1093/carcin/bgt208
[Link to Article]
Colin Clarke, Stephen F. Madden, Padraig Doolan, Sinead T. Aherne, Helena Joyce, Lorraine O’Driscoll, William M. Gallagher, Bryan T. Hennessy, Michael Moriarty, John Crown, Susan Kennedy, Martin Clynes
2013 BreastMark: an integrated approach to mining publicly available transcriptomic datasets relating to breast cancer outcome
 
Breast Cancer Res. 2013 Jul 2;15(4):R52, doi:10.1186/bcr3444
[Link to Article]
Stephen F. Madden, Colin Clarke, Sinead T. Aherne, Patricia Gaule, Norma O'Donovan, John Crown, Martin Clynes, William M. Gallagher
2013 Biomarkers in drug discovery and development
 
Book chapter, Encyclopedia of Pharmaceutical Science and Technology, 4th edition, Informa Healthcare, doi:10.1081/E-EPT4-120050197
[Link to Article]
Miriam A Lynn, Gillian O'Hurley, Adrian Coyle, Balazs Balint, Marina Alamanou, William M. Gallagher
Conferences
2017 High CDK7 is Linked to Poor Outcome in Triple-Negative Breast Cancer and is a Rational Therapeutic Target
 
Irish Association for Cancer Research (IACR), Kilkenny, Ireland, 24th February 2017
Li B, Ni Chonghaile T, O'Connor D, Gallagher W et al.
2016 Phase II of POSEIDON: A phase Ib / randomized phase II trial of tamoxifen plus taselisib or placebo in hormone receptor positive, HER2 negative, metastatic breast cancer patients with prior exposure to endocrine treatment
 
San Antonio Breast Cancer Symposium 2016, Texas, USA, 6-10th Dec 2016
Oliveira M (VHIO), Baird RD, van Rossum A, Beelen K, Garcia-Corbacho J, Mandjes I, Vallier AL, van Werkhoven E, Garrigós L, Kumar S, van Tinteren H, Muñoz S, Linossi C, Rosing H, Miquel JM, Schrier M, de Vries Schultink A, Saura C, Gallagher WM, Bernards R, Tabernero J, Cortés J, Caldas C and Linn S
2016 POSEIDON trial phase 1b results: Safety and preliminary efficacy of the isoform selective PI3K inhibitor taselisib (GDC0032) combined with tamoxifen in hormone receptor (HR) positive, HER2-negative metastatic breast cancer (MBC) patients (pts) including response monitoring by plasma circulating tumour (ct) DNA
 
Poster, ASCO 2016, and selected for Poster Discussion session, Chicago, USA, 3-7th Jun 2016
Richard D. Baird (CAM), Annelot Van Rossum, Mafalda Oliveira, Karin Beelen, Javier GarciaCorbacho, Ingrid A M Mandjes, AnneLaure Vallier, Erik D. van Werkhoven, Sanjeev Srinivas Kumar, Harm van Tinteren, Emma Beddowes, Hilde Rosing, Mariette Schrier, Aurelia de Vries Schultink, Cristina Saura, Rene Bernards, Josep Tabernero, Javier Cortes, Carlos Caldas, Sabine C. Linn
2016 Master regulators of breast tumour progression: a source of robust prognostic biomarkers
 
Talk, Clinical Decision Support Systems for Breast and Prostate Cancer, Dublin, Ireland, 7-8th Mar 2016
William Gallagher (UCD)
2016 Bromodomain Inhibitors for the Treatment of Invasive Lobular Carcinoma
 
Irish Association for Cancer Research Annual Conference Cork, Ireland, 24th – 26th February 2016
Louise Walsh (UCD), Finbarr Tarrant, Ye Fan, William M. Gallagher, Tríona Ní Chonghaile, Darran P. O’Connor
2016 Epigenetic Modulators for the Treatment of Invasive Lobular Carcinoma Breast Cancer
 
Poster, International Cell Death Society Conference Cork, Ireland, 2nd – 4th June 2016
Louise Walsh (UCD), Finbarr Tarrant, Ye Fan, William M. Gallagher, Tríona Ní Chonghaile, Darran P. O’Connor
2016 Epigenetic Modulators for the Treatment of Invasive Lobular Carcinoma Breast Cancer
 
Poster, European Association for Cancer Research conference series ‘A Matter of Life or Death’ Amsterdam, Netherlands, 9th – 11th May 2016
Louise Walsh (UCD), Finbarr Tarrant, William M. Gallagher, Tríona Ní Chonghaile, Darran P. O’Connor
20 Protein-based assays: how to position them in personalised medicine trials
 
Talk, Molecular Analysis For Personalised Therapy (MAP) Conference, Paris, France, 23-24th Oct 2015
Leanne De Koning (IC)
2015 RPPA as a Tool to Identify New Biomarkers and Potential Therapeutic Targets for Invasive Lobular Breast Cancer
 
Talk, Global RPPA Workshop, Virginia, USA, 12-13th Oct 2015
Leanne De Koning (IC)
2015 Epigenetic modulators for the treatment of Invasive Lobular Carcinoma Breast Cancer
 
Talk, Royal Academy of Medicine Ireland, Dublin, Ireland
Louise Walsh, T Ni Chonghaile, Y Fan, DP O'Connor, WM Gallagher
2015 Reverse Phase Protein Arrays as a tool to identify new biomarkers and potential therapeutic targets for breast cancer subtypes
 
Talk, SELECTBIO Microarray Technology conference, Berlin, Germany, 17th-18th March 2015
Leanne De Koning
2015 CDK7: A marker of poor prognosis and tractable therapeutic target in triple-negative breast cancer
 
Talk, Irish Association of Cancer Research Annual meeting, 26th-27th February 2015, Limerick, Ireland
Bo Li, T Ni Chonghaile, Y Fan, R Kinger, AE O'Connor, DP O'Connor, WM Gallagher
2015 Epigenetic modulators for the treatment of Invasive Lobular Carcinoma Breast Cancer
 
Poster, Irish Association of Cancer Research Annual meeting, 26th-27th February 2015, Limerick, Ireland
Louise Walsh, T Ni Chonghaile, Y Fan, DP O'Connor, WM Gallagher
2014 New treatment strategy of invasive lobular carcinoma
 
Poster, Cell Symposia: Hallmarks of Cancer: Asia. 9th November, 2014, Beijing, China
Z. Xue, I. Majewski, M. Michaut, A. Bosma, P. Halonen, L. Wessels, R. Bernards
2014 Deciphering protein signaling networks in lobular breast cancer samples
 
Seminar, Institut Curie, Paris, France, 7th Oct 2014
Leanne De Koning
2014 RATHER: High Resolution Molecular Profiling of Lobular and Triple Negative Breast Cancers
 
Poster, Beyond Genome Boston, USA, 8th-10th October 2014
Suet-Feung Chin, Oscar Rueda, Bernard Pereira, Ian Majewski, Yue Fan, Finbarr Tarrant, Magali Michaut, Justine Peeters, Philip Schouten, Leanne de Koning, Beilei He, Sarah McGuire, Helen Bardwell, Elena Provenzano, Darran P. O’Connor, Jeroen Heijmans, Mireille Snel, Tesa Severson, Astrid Bosma, Lorenza Mittempergher, Tycho Bismeijer, Sabine Linn, Thierry Dubois, Lodewyk Wessels, Iris Simon, William M. Gallagher, René Bernards, Carlos Caldas
2014 Epigenetic modulators for the treatment of Invasive Lobular Carcinoma Breast Cancer
 
Poster, Conway Festival, University College Dublin. 10th September 2014
Louise Walsh, T Ni Chonghaile, Y Fan, DP O'Connor, WM Gallagher
2014 Reverse phase protein array profiling of Lobular and Triple Negative Breast Cancers within the RATHER consortium
 
Poster, EACR Annual Meeting 2014, 5th-8th July, Munich, Germany
Leanne de Koning, Beilei He, Aurélie Barbet, Floriane Bard, Caroline Lecerf, Céline Baldeyron, Thierry Dubois
2014 RATHER: high resolution molecular profiling of lobular and triple negative breast cancers
 
Poster, EACR Annual Meeting 2014, 5th-8th July, Munich, Germany
Suet-Feung Chin, Oscar Rueda, Bernard Pereira, Ian Majewski, Yue Fan, Finbarr Tarrant, Magali Michaut, Justine Peeters, Philip Schouten, Leanne de Koning, Beilei He, Sarah McGuire, Helen Bardwell, Elena Provenzano, Darran P. O’Connor, Jeroen Heijmans, Mireille Snel, Tesa Severson, Astrid Bosma, Lorenza Mittempergher, Tycho Bismeijer, Sabine Linn, Thierry Dubois, Lodewyk Wessels, Iris Simon, William M. Gallagher, René Bernards, Carlos Caldas
2014 Development of a BRCA1-like signature in triple negative breast cancers within the RATHER (Rational Therapy for Breast Cancer) Consortium
 
Poster, IMPAKT 2014 Breast Cancer Conference, Brussels, Belgium, 8th-10th May 2014
I. Simon, J. Peeters, T. Severson, I. Majewski, A. Bosma, S-F. Chin, C. Caldas, R. Bernards, S. Linn
2014 Identification of novel kinase targets in triple-negative breast cancer
 
Poster, Irish Association of Cancer Research Annual Meeting, 27th-28th February 2014, Galway, Ireland
Bo Li, Yue Fan, Aisling O'Connor, Rut Klinger, Kate Connor, Darran O'Connor, and William M. Gallagher
2013 Identification of novel kinase targets in triple-negative breast cancer
 
Poster, Conway Festival, University College Dublin
Bo Li, Yue Fan, Aisling O'Connor, Rut Klinger, Kate Connor, Darran O'Connor, and William M. Gallagher
2013 Defining clinically relevant molecular subtypes in lobular breast cancer within the RATHER Consortium
 
Poster, San Antonio Breast Cancer Symposium 2013, USA
Sabine Linn, Ian Majewski, Magali Michaut, Justine Peeters, Philip Schouten, Leanne de Koning, Beilei He, Yue Fan, Finbarr Tarrant, Darran P. O’Connor, Oscar Rueda, Suet-Feung Chin, Jeroen Heijmans, Mireille Snel, Tesa Severson, Astrid Bosma, Lorenza Mittempergher, Tycho Bismeijer, Thierry Dubois, Lodewyk Wessels, Iris Simon, William M. Gallagher, Carlos Caldas, René Bernards
2013 RATHER: High Resolution Molecular Profiling of Lobular and Triple Negative Breast Cancers
 
Poster, AACR Advances in Breast Cancer, 3rd -6th October 2013, San Diego, USA
Suet-Feung Chin, Oscar Rueda, Bernard Pereira, Ian Majewski, Yue Fan, Finbarr Tarrant, Magali Michaut, Justine Peeters, Philip Schouten, Leanne de Koning, Beilei He, Sarah McGuire, Helen Bardwell, Elena Provenzano, Darran P. O’Connor, Jeroen Heijmans, Mireille Snel, Tesa Severson, Astrid Bosma, Lorenza Mittempergher, Tycho Bismeijer, Sabine Linn, Thierry Dubois, Lodewyk Wessels, Iris Simon, William M. Gallagher, René Bernards, Carlos Caldas
2013 Identification of novel kinase targets in triple-negative breast cancer
 
Poster, Conway Festival, 11th-12th September 2013, University College Dublin, Ireland
Bo Li, Yue Fan, Aisling O'Connor, Rut Klinger, Kate Connor, Darran O'Connor, and William M. Gallagher
2013 Revealing Kinase Deregulation in Lobular Breast Cancer via High-Throughput Molecular Profiling Within the RATHER Consortium
 
Poster, The Genomics of Common Diseases Conference 2013, Oxford, UK
Yue Fan, Finbarr Tarrant, Ian Majewski, Magali Michaut, Justine Peeters, Philip Schouten, Leanne de Koning, Beilei He, Darran P. O’Connor, Oscar Rueda, Suet-Feung Chin, Jeroen Heijmans, Mireille Snel, Tesa Severson, Astrid Bosma, Lorenza Mittempergher, Tycho Bismeijer, Sabine Linn, Thierry Dubois, Lodewyk Wessels, Iris Simon, William M. Gallagher, Carlos Caldas, René Bernards
2013 Investigation of BRCA1-like signature in triple negative breast cancers within the RATHER (Rational Therapy for Breast Cancer) Consortium
 
Poster, AACR Annual Meeting 2013, Washington DC, USA
Tesa Severson, Justine Peeters, Ian Majewski, Astrid Bosma, Suet-Feung Chin, Carlos Caldas, Iris Simon, René Bernards, Sabine Linn
2013 DNA repair genes and BRCA1-like classification in the RATHER triple negative breast cancers
 
Poster, Breakthrough Breast Cancer Triple Negative Breast Cancer Conference 2013, London, UK, 26th-28th June, 2013
Tesa Severson, Justine Peeters, Ian Majewski, Magali Michaut, Philip Schouten, Astrid Bosma, Suet-Feung Chin, Carlos Caldas, Iris Simon, Lodewyk Wessels, René Bernards, Sabine Linn
2013 Development of comprehensive molecular portraits of lobular breast cancer within the RATHER (Rational Therapy for Breast Cancer) Consortium
 
Poster, AACR Annual Meeting 2013, Washington DC, USA
Justine Peeters, Ian Majewski, Leanne de Koning, Yue Fan, Finbarr Tarrant, Darran O. O'Connor, Jeroen Heijmans, Mireille Snel, Tesa Severson, Astrid Bosma, Magali Michaut, Lorenza Mittempergher, Beilei HE, Thierry Dubois, William M. Gallagher, Carlos Caldas, René Bernards, Iris Simon
2013 Development of comprehensive molecular portraits of lobular breast cancer within the RATHER (Rational Therapy for Breast Cancer) Consortium
 
Talk, IACR Annual Meeting 2013, Dublin, Ireland
Yue Fan, Finbarr Tarrant, Darran P. O’Connor, Ian Majewski, Justine Peeters, Leanne de Koning, Kate Connor, Jeroen Heijmans, Mireille Snel, Tesa Severson, Astrid Bootsma, Magali Michaut, Lorenza Mittempergher, Thierry Dubois, Iris Simon, Carlos Caldas, René Bernards, William M. Gallagher
2012 Kinome capture sequencing to discover new signalling pathways that contribute to cancer pathogenesis
 
Poster, 24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, Dublin
Ian Majewski, Zheng Xue, Lorenza Mittempergher, Magali Michaut, Roel Kluin, Astrid Bosma, Justine Peeters, Leanne de Koning, Thierry Dubois, Lodewyk Wessels and René Bernards
Invited Talks
2016 A Vulnerability of Drug Resistant Melanomas With Therapeutic Implications
 
Symposia on Cancer Research 2016 – Cancer evolution: the mechanisms of vulnerability and resistance; MD Anderson Cancer Centre, Texas, USA, 6th Oct 2016
René Bernards (NKI)
2016 Molecular heterogeneity in ILC
 
Talk, 1st International Invasive Lobular Cancer Symposium, Pittsburgh, USA, 29-30th Sept 2016
Suet-Feung Chin (CAM)
2015 Translation of omic data into personalised oncology tools: the challenge and the reward
 
Select Biosciences Online Conference – Diagnostics & Biomarkers, 27 – 28 January 2015
William Gallagher
2014 Fast-tracking molecular diagnostics in oncology via antibody-based proteomics and digital pathology
 
Royal College of Surgeons in Ireland/Beaumont Hospital, Dublin, 23 April 2014
William Gallagher
2014 Development of a campus spinout: one foot in academia and the other in industry
 
Irish Association for Cancer Research, Galway, 27-28 February 2014
William Gallagher
2014 Fast-tracking molecular diagnostics in oncology via antibody-based proteomics and digital pathology
 
University of Torino, Torino, 3 February 2014
William Gallagher
2013 Towards precision medicine in oncology: The advent of molecular diagnostics
 
Association of Clinical Biochemists in Ireland (36th Annual Conference), Dublin, 18 – 19 October 2013
William Gallagher
2013 Getting EU funding: The experience of the RATHER project
 
Horizon 2020 Health Information Day, European Commission, Centre Albert Borschette, Brussels, 22 November 2013
William Gallagher
2013 Tackling the validation bottleneck: Fast-tracking molecular diagnostics in oncology via antibody-based proteomics and digital pathology
 
Bioconference Live 2013, Cancer: Research, Discovery and Therapeutics, 16 – 17 October 2013
William Gallagher
2013 Fast-tracking molecular diagnostics in oncology via antibody-based proteomics and digital pathology
 
Molecular Medicine Congress 2013: Biomarkers and Applications of Exosomes Track, Frankfurt, 3 – 4 September 2013
William Gallagher
2013 Development of a campus spinout: one foot in academia and the other in industry
 
Irish Association for Cancer Research, Maynooth, 14 May 2013
William Gallagher
2013 Industry-academic partnerships in the oncology molecular diagnostics sector
 
Life Sciences Summit, Dublin, 1 March 2013
William Gallagher
2013 Translational perspectives in cancer biology: case studies in biomarker and drug development
 
University College Cork Seminar Series, 12 February 2013
William Gallagher
2013 Advice from a “successful” FP7 co-ordinator
 
FP7 Health Co-Ordinators Support Workshop, Dublin, 9 January 2013
William Gallagher
2012 Fast-tracking molecular diagnostics in oncology via antibody-based proteomics and digital pathology
 
KU Leuven, Leuven, 11 December 2012
William Gallagher
2012 Fast-tracking molecular diagnostics in oncology via antibody-based proteomics and digital pathology
 
Cancer Proteomics 2012, Madrid, 16 – 17 October 2012
William Gallagher
2012 Aiding biomarker development through effective industry-academia partnerships
 
3rd Annual External & Collaborative Innovation in Life Science R&D, London, 3 October 2012
William Gallagher
2012 All-board the brain train! Experiences of Europe’s global scientific diaspora
 
Wild Geese Careers Forum, EuroScience Open Forum 2012, Dublin, 11 – 15 July 2012
William Gallagher
2012 Fast-tracking molecular diagnostics in oncology via antibody-based proteomics and digital pathology
 
Next Generation Molecular Diagnostics, Prague, 12 – 13 June 2012
William Gallagher
2012 OncoMark: case study presentation
 
Collaborate to Innovate (European Research & Innovation Funding for SMEs), Belfast, 7 June 2012
William Gallagher
2012 OncoMark: a case study in innovation within the life sciences sector
 
Ireland’s Presidential Priorities: Jobs and Innovation, Dublin, 22 May 2012
William Gallagher
2012 Fast-tracking molecular diagnostics in oncology via antibody-based proteomics and digital pathology
 
Molecular Diagnostics Europe 2012 (Disease Biomarkers Track), London, 10 – 11 May 2012
William Gallagher
2012 Towards tailored treatment for triple negative breast cancer and invasive lobular carcinoma of the breast: a kinase-centric viewpoint (RATHER)
 
AACR Annual Meeting 2012, Chicago
René Bernards
2012 Fast-tracking molecular diagnostics in oncology via antibody-based proteomics and digital pathology
 
Genomics Research 2012 (Genomic Biomarkers Track), Boston, 19 – 20 April 2012
William Gallagher
2012 Fast-tracking molecular diagnostics in oncology via antibody-based proteomics and digital pathology
 
Advances in Microarray Technology 2012, Edinburgh, 28 – 29 March 2012
William Gallagher
2012 OncoMark: A case study of innovation
 
European Universities Centre Symposium 2012, Dublin, 12 March 2012
William Gallagher
2012 Case study presentation – EU projects in the cancer arena
 
UCD Focus on Industry-Academia Partnership and Pathways Programme, Dublin, 14 February 2012
William Gallagher
2012 Aiding biomarker development through effective industry-academia partnerships
 
Biomarkers Summit 2012, London, 16 – 17 January 2012
William Gallagher
2012 Fast-tracking molecular diagnostics in oncology via antibody-based proteomics and digital pathology
 
Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, 11 January 2012
William Gallagher
2011 Antibody-based proteomics: fast-tracking molecular diagnostics in oncology
 
International Conference on ‘Omics Meets Disease’ and 3rd Annual Meeting of Proteomics Society (India), Kolkata, 15 – 18 December 2011
William Gallagher
2011 Antibody-based proteomics: fast-tracking molecular diagnostics in oncology
 
iSymposia Online Conference ‘Mining for Cancer Biomarkers: From Genes to Tissues’, 13 – 15 December 2011
William Gallagher
2011 Case study presentation – EU projects in the cancer arena
 
InterTradeIreland - Focus on FP7 Series - Cancer Research. Dublin, 17 November 2011
William Gallagher
2011 Workshop on European Framework Programme
 
SFI Science Summit 2011 (Shaping the Future Now – New Horizons for Science and Society), Athlone, 14 – 15 November 2011
William Gallagher
2011 Fast-tracking molecular diagnostics in oncology via antibody-based proteomics and digital pathology
 
BioConference Live Fall: Life Sciences, 26-27 October 2011 [see Archived presentation on www.bioconferencelive.com]
William Gallagher
2011 Antibody-based proteomics: translating omic datasets into clinically relevant assays
 
Microarray World Congress, San Francisco, 29 – 30 September 2011
William Gallagher
2011 Translational perspectives in cancer biology: case studies in biomarker and drug development
 
11th Annual Conway Festival of Research and Innovation, Dublin, 15 September 2011 *Plenary Speaker
William Gallagher
2011 Antibody-based proteomics: translating omic datasets into clinically relevant assays
 
Beckman Coulter 2011 Science & Technology Symposium “Cancer Diagnostics – Confronting the Complexity”, Brea, CA, 6 – 7 July 2011
William Gallagher
2011 Bridging the translational divide: converting omic datasets into clinically relevant assays
 
Advances in Microarray Technology 2011 (part of European Lab Automation conference), Hamburg, 30 June – 1 July 2011
William Gallagher
2011 Bridging the translational divide: converting omic datasets into clinically relevant assays
 
EMBO Cancer Proteomics 2011, Dublin, 20 – 23 June 2011
William Gallagher
2011 Translational persectives in cancer biology: case studies in biomarker and drug development
 
Institute of Molecular Medicine Lecture Series, Dublin, 23 May 2011
William Gallagher
2011 A systematic investigation of tumour biomarkers: taking advantage of the digital pathology framework
 
European Biomarkers Summit 2011, London, 18 – 19 May 2011 *Keynote seminar
William Gallagher
2011 Proteomics in the discovery of circulating biomarkers in cancer. Educational Session on “Clinical Use of Circulating Biomarkers: The Good, The Bad and the Ugly”
 
102nd Annual Conference of the American Association for Cancer Research, Orlando Florida, 2 – 6 April 2011
William Gallagher
2011 Tissue-based imaging: automated image analysis approaches in histopathology
 
Quantitative Biology and Bioinformatics in Modern Medicine – International Conference, University College Dublin, 7 – 8 February 2011
William Gallagher
Dissemination to Lay Persons
2016 Breast Cancer – the answer is in Epigenetics?
 
Thesis in 3, Royal College of Surgeons, Ireland, 2016
Louise Walsh (UCD), Finbarr Tarrant, Ye Fan, William M. Gallagher, Tríona Ní Chonghaile, Darran P. O’Connor
2015 Discussing RATHER and the POSEIDON clinical trial
 
CRCfm (local Irish radio station), Oct 2015
Karen Misstear (OM)
2015 Targeting the drivers of difficult-to-treat breast cancers
 
European Commission Horizon 2020 article about the RATHER project and clinical trial, for World Cancer Day – 4th Feb 2015
2014 EU breast cancer research targets personalised treatment
 
European Commission press release, 27th Oct 2014, referencing RATHER as a promising breast cancer research programme
2014 Cancer knows no boundaries- but we can slow death rate
 
Newspaper article in the Irish Independent newspaper for World Cancer Day
Marie Geoghegan Quinn, the EU Commissioner for Research, Innovation and Science. Referencing the Irish RATHER partners UCD and OM.
2014 Laura van't Veer was rewarded 2nd prize as best EU Women Innovator 2014
 
AG
2013 Getting EU funding: The Experience of the RATHER project
 
Horizon 2020 Health Information Day, European Commission, Brussels, 22 November 2013
2012 The True Cost of Personalised Cancer Medicine
 
EuroScience Open Forum (ESOF12) 2012
William M Gallagher, Iris Simon
2012 iInterview by Dr. Alberto Cambrosio
 
Focus on universities and innovative spinout companies. Department of Social Studies of Medicine McGill University, Montreal Mon 23 Apr 2012
William M Gallagher, Máirín Rafferty, René Bernards, Iris Simon
2011-2015 Various press releases
 
UCD, OM, AG, EC